![Chris Boshoff](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Chris Boshoff
President bij
SEAGEN INC.
Vermogen: 4 M $ op 31-05-2026
Profiel
Chris Boshoff currently works at Pfizer Inc., as President-R&D & Chief Scientific Officer from 2025, Seagen, Inc., as President from 2023, and Pfizer (La Jolla), as Vice President-Translational Oncology.
Dr. Boshoff also formerly worked at Advanced Oncotherapy Plc, as Non-Executive Director in 2013 and UCL Cancer Institute Research Trust, as Founding Director.
Dr. Boshoff received his doctorate degree from Institute of Cancer Research Royal Marsden Hospital.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 03-03-2026 | 162.088 ( 0% ) | 4 M $ | 31-05-2026 |
Laatste nieuws over Chris Boshoff
Actieve functies van Chris Boshoff
| Bedrijven | Functie | Begin |
|---|---|---|
| PFIZER INC. | Hoofd Techniek/Wetenschap/O&O | 01-01-2025 |
| SEAGEN INC. | President | 14-12-2023 |
Pfizer (La Jolla)
 Pfizer (La Jolla) Miscellaneous Commercial ServicesCommercial Services Provides research services | Corporate Officer/Principal | - |
Eerdere bekende functies van Chris Boshoff
| Bedrijven | Functie | Einde |
|---|---|---|
| ADVANCED ONCOTHERAPY PLC | Directeur/Bestuurslid | 25-10-2013 |
UCL Cancer Institute Research Trust | Directeur/Bestuurslid | - |
Opleiding van Chris Boshoff
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
25
Eerstegraads connecties
6
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Seagen, Inc.
 Seagen, Inc. Pharmaceuticals: MajorHealth Technology Develops monoclonal antibody-based therapeutic products for treatment of cancer and immunologic diseases | Health Technology |
Advanced Oncotherapy Plc
 Advanced Oncotherapy Plc Medical SpecialtiesHealth Technology Develops and provides advanced cancer treatments | Health Technology |
Pfizer (La Jolla)
Pfizer (La Jolla) Miscellaneous Commercial ServicesCommercial Services Provides research services | Commercial Services |
UCL Cancer Institute Research Trust | |
Institute of Cancer Research Royal Marsden Hospital
 Institute of Cancer Research Royal Marsden Hospital Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
